Clinical Cancer Genetics Program
Karen Lu, M.D.
Banu Arun, M.D.
Breast Medical Oncology
Approximately 5-10% of cancer is inherited. Individuals with a genetic predisposition will have a far higher chance of developing cancer within their lifetime and at an earlier age. Genetic testing can help determine whether a family has a hereditary cancer predisposition syndrome. Individuals who have genetically higher risks to develop certain cancers are recommended to follow high-risk cancer surveillance and management. The Clinical Cancer Genetics Program can coordinate genetic testing and high-risk cancer surveillance for individuals and their families with hereditary cancer syndromes. For further information please view our
Familial Adenomatous Polyposis (FAP) Patient Education Conference
Saturday, May 10, 2014
8:30 am – 2:15 pm
Cancer Prevention Building, 8th Floor, 1155 Pressler Street
* Registration is FREE begins at 8:00 am.
The Clinical Cancer Genetics Program presents an opportunity for patients to learn about the latest developments in clinical care and research focusing on this hereditary syndrome.
Agenda Items Include:
- Overview of FAP
- Importance of knowing your family health history
- Updates on genetic testing
- Surveillance of the GI Tract
- Round-table discussions with MD Anderson experts
Pressler garage Pressler Dr between Fannin & Bertner)
Use the skybridge on the 4th floor of garage and follow signs to the Cancer Prevention Building
Conference Brochure (pdf)